Skip to main content
. 2022 May 11;11(5):948. doi: 10.3390/antiox11050948

Figure 8.

Figure 8

Viabilities of B16F10 cells treated with analogs 1, 2, 3, or 6. Cell viabilities after 24 or 48 h of treatment were assessed using the EZ-Cytox assay at six different concentrations (0, 1, 2, 5, 10, or 20 µM). Results are presented as percentages of non-treated controls and bars show standard errors. All experiments were performed independently in triplicate.